The Mounjaro weight-loss jab is now available from GPs the NHS, but only for a limited group of patients with a BMI over 35 ...

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.

NHS weight-loss jabs are set to become available in pharmacies over the coming years as part of a plan to boost the nation’s ...

Novo Nordisk just pulled Wegovy from a major telehealth platform over safety concerns about knockoff versions. Here's what ...

As the NHS rolls out Mounjaro being prescribed by GPs, weight loss jabs have been linked to potentially fatal side effects in new data ...

UnitedHealth Group’s ( UNH) new CEO, Stephen Hemsley, is shaking up the senior management of the company, appointing Patrick Conway, newly named CEO of the managed care giant’s Optum unit, as the head ...

Enter global pharmaceutical giants. US-based Eli Lilly and Novo Nordisk have both launched GLP-1-based treatments in India in ...

Grey market grows for cheap weight-loss drugs imported from China Some users try small doses of substances not yet approved ...

Rochelle McDonald has just been through the messiest of break-ups. “Guzman y Gomez were devastated,” she says, but 17 kilos ...

There have been 181 cases of acute/chronic pancreatitis and five deaths linked to Mounjaro, while Ozempic and Wegovy have one death and 113 pancreatitis reports attached to them (via Sky News).

Plain Facts compilation, we present to you data-based insights, with easy-to-read charts, to help you delve deeper into the ...

A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...